Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05920083Not ApplicableTerminated

Obstructive Sleep Apnea - Autonomic and Vascular Exploration

Role: lead

NCT03959280Not ApplicableUnknown

CPAP, Nutrition & Exercise Against Sleep Apnea

Role: lead

NCT04394143Phase 2Completed

Effect of AD128 to Treat Obstructive Sleep Apnea

Role: lead

NCT03753971Not ApplicableCompleted

Early Sleep Apnea Termination Using Sound Stimulation

Role: lead

All 4 trials loaded